Skip to main content
OpenTrials

Clinical trial condition

Scleroderma

Explore clinical trials studying Scleroderma. Study availability and eligibility vary by location and protocol.

120 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma trial results

Active, not recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

NCT06843239

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • UCSD Altman Clinical and Translational Research Institute Center for Clinical Research La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 60 locations
View Trial Details
Completed

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

NCT06587828

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +51 more
Locations
  • Knowledge Research Center Orange, California, United States
  • Cura Clinical Research Sherman Oaks, California, United States
  • Arnold Arthritis & Rheumatology Skokie, Illinois, United States
  • University of Kentucky Research Foundation Lexington, Kentucky, United States
View Trial Details
Completed

TENS in Scleroderma

NCT06646913

Conditions
Connective Tissue Diseases, Digestive System Diseases, Gastrointestinal Diseases, +12 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

Brentuximab Vedotin for Systemic Sclerosis

NCT03222492

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, +5 more
Locations
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • Georgetown University Medical Center: Division of Rheumatology Washington D.C., District of Columbia, United States
  • University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology Ann Arbor, Michigan, United States
  • Hospital for Special Surgery, New York: Division of Rheumatology New York, United States
View Trial Details
Completed

Hyaluronidase Via LADD Scleroderma-induced Microstomia

NCT05995626

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • University of Nebraska Medical Center, Lauritzen Outpatient Center Omaha, Nebraska, United States
  • Nebraska Medicine, Dermatology Westroads Omaha, Nebraska, United States
View Trial Details

Related conditions